Prionas S D, Kapp D S, Goffinet D R, Ben-Yosef R, Fessenden P, Bagshaw M A
Department of Radiation Oncology, Stanford University School of Medicine, CA 94305.
Int J Radiat Oncol Biol Phys. 1994 Jan 1;28(1):151-62. doi: 10.1016/0360-3016(94)90153-8.
Recurrence in the prostatic gland remains a significant problem in the management of locally advanced prostatic cancer. Transperineal thermobrachytherapy has been utilized in an attempt to improve local tumor control. The purpose of this study was to quantitate the temperature distributions obtained in carcinoma of the prostate treated with interstitial radiofrequency-induced hyperthermia given in conjunction with 192Ir brachytherapy in a Phase I study.
From 1987 until 1992, 36 patients (5 with locally recurrent, 15 with Stage B, and 16 Stage C prostate cancers) were treated with interstitial brachytherapy implants supplemented with radiofrequency-induced hyperthermia. An array of 7-32 stainless steel trocar electrodes (outer diameter = 1.5 mm, interelectrode spacing = 8 mm) were implanted into the prostate gland through a perineal approach utilizing a specially designed template. Each trocar was electrically insulated along the length which traversed surrounding normal tissues. One to three additional plastic catheters were implanted for automated temperature mapping. Thirty-four of these procedures were performed following lymph node sampling. However, the last two removable interstitial hyperthermic prostate implants were done by the transperineal route under ultrasound guidance. A hyperthermia treatment (goal of 43 degrees C for 45 minutes) was given immediately prior to the insertion and immediately following the removal of the 192Ir. A computer-controlled radiofrequency-based generator (freq. 0.5 MHz) implementing electrode multiplexing was used to induce and maintain elevated temperatures.
Transient local pain was the most common treatment limiting factor. The average values of the measured minimum, mean, and maximum temperatures were 38.9 degrees C, 41.9 degrees C, and 45.7 degrees C in tumor, and 37.7 degrees C, 39.8 degrees C, and 42.9 degrees C in surrounding normal tissue, respectively. The percentages of mapped temperatures exceeding 41 degrees C, 42 degrees C, and 43 degrees C were 67%, 46%, and 27% in tumor, and 26%, 11%, and 4% in normal surrounding tissue, respectively.
From this study we conclude that heterogeneous temperature distributions were induced in the prostate; significant normal tissue protection was realized in part through the selective insulation of sections of each electrode; and interstitial radiofrequency-induced hyperthermia of the prostate is feasible and well tolerated, with further technical developments warranted.
前列腺癌复发仍是局部晚期前列腺癌治疗中的一个重大问题。经会阴热近距离放射治疗已被用于尝试改善局部肿瘤控制。本研究的目的是在一项I期研究中,对联合192Ir近距离放射治疗的间质射频诱导热疗治疗前列腺癌时获得的温度分布进行定量分析。
1987年至1992年,36例患者(5例局部复发、15例B期和16例C期前列腺癌)接受了间质近距离放射治疗植入,并辅以射频诱导热疗。通过会阴途径,利用专门设计的模板,将一组7 - 32根不锈钢套管针电极(外径 = 1.5 mm,电极间距 = 8 mm)植入前列腺。每根套管针在穿过周围正常组织的长度上进行电绝缘。另外植入1 - 3根塑料导管用于自动温度测绘。其中34例手术在淋巴结取样后进行。然而,最后两根可移除的间质热疗前列腺植入物是在超声引导下经会阴途径完成的。在插入192Ir之前和移除192Ir之后立即进行热疗(目标温度为43℃,持续45分钟)。使用基于计算机控制的射频发生器(频率0.5 MHz)实施电极复用,以诱导并维持体温升高。
短暂的局部疼痛是最常见的治疗限制因素。肿瘤中测量的最低、平均和最高温度的平均值分别为38.9℃、41.9℃和45.7℃,周围正常组织中分别为37.7℃、39.8℃和42.9℃。肿瘤中温度超过41℃、42℃和43℃的测绘温度百分比分别为67%、46%和27%,周围正常组织中分别为26%、11%和4%。
从本研究中我们得出结论,前列腺中诱导出了不均匀的温度分布;部分通过对每个电极部分的选择性绝缘实现了对正常组织的显著保护;前列腺间质射频诱导热疗是可行的且耐受性良好,值得进一步进行技术开发。